Questions?
REQUEST A MEDICAL SCIENCE LIAISON (MSL)
Questions?
REQUEST A MEDICAL SCIENCE LIAISON (MSL)
Actor portrayals.For your patients with pulmonary arterial hypertension (PAH, WHO Group I)
Studied in GRIPHON, the largest PAH pivotal trial with the longest endpoint evaluation period of any prostacyclin pathway therapy1-3
Learn More
Consistent safety profile across GRIPHON (N=1156) and open-label extension (OLE)1,4
See Safety
Clicking CONTINUE below will take you to the selected site, the content for which Johnson & Johnson is not responsible and to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every online service you visit.
The following form is intended for use with patients who are eligible for VA benefits only.
This article includes information that has not been approved by the Food and Drug Administration for UPTRAVI® (selexipag). Please see full Prescribing Information available on this website. Authors[s] of this article have received remuneration from Actelion Pharmaceuticals US, Inc., or its affiliates.
